Lindbrook Capital’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $6.31K | Buy |
260
+117
| +82% | +$2.84K | ﹤0.01% | 1861 |
|
|
2024
Q4 | $2.98K | Buy |
143
+3
| +2% | +$63 | ﹤0.01% | 2180 |
|
|
2024
Q3 | $2.78K | Hold |
140
| – | – | ﹤0.01% | 2242 |
|
|
2024
Q2 | $2.17K | Buy |
140
+109
| +352% | +$1.69K | ﹤0.01% | 2321 |
|
|
2024
Q1 | $494 | Sell |
31
-207
| -87% | -$3.3K | ﹤0.01% | 2519 |
|
|
2023
Q4 | $4K | Buy |
238
+150
| +170% | +$2.52K | ﹤0.01% | 2008 |
|
|
2023
Q3 | $1.03K | Buy |
88
+51
| +138% | +$596 | ﹤0.01% | 2351 |
|
|
2023
Q2 | $497 | Sell |
37
-23
| -38% | -$309 | ﹤0.01% | 2513 |
|
|
2023
Q1 | $995 | Sell |
60
-56
| -48% | -$929 | ﹤0.01% | 2451 |
|
|
2022
Q4 | $2.16K | Sell |
116
-340
| -75% | -$6.33K | ﹤0.01% | 2200 |
|
|
2022
Q3 | $6K | Buy |
456
+453
| +15,100% | +$5.96K | ﹤0.01% | 1548 |
|
|
2022
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 2533 |
|
|
2022
Q1 | $0 | Buy |
+3
| New | – | ﹤0.01% | 2493 |
|